Extracting Regulatory Active Chromatin Footprint from Cell-Free DNA

preprint OA: closed
Full text JSON View at publisher
Full text 14,291 characters · extracted from preprint-html · click to expand
Extracting Regulatory Active Chromatin Footprint from Cell-Free DNA | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Extracting Regulatory Active Chromatin Footprint from Cell-Free DNA Kevin Lai, Katharine Dilger, Rachael Cunningham, Kathy Lam, Rhea Boquiren, and 4 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-3983393/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 04 Sep, 2024 Read the published version in Communications Biology → Version 1 posted You are reading this latest preprint version Abstract Cell-free DNA (cfDNA) has emerged as a pivotal player in precision medicine, revolutionizing the diagnostic and therapeutic landscape. While its clinical applications have significantly increased in recent years, current cfDNA assays have limited ability to identify the active transcriptional programs that govern complex disease phenotypes and capture the heterogeneity of the disease. To address these limitations, we have developed a non-invasive platform to enrich and examine the active chromatin fragments (cfDNA ac ) in peripheral blood. The deconvolution of the cfDNA ac signal from traditional nucleosomal chromatin fragments (cfDNA nuc ) yields a catalog of features linking these circulating chromatin signals in blood to specific regulatory elements across the genome, including enhancers, promoters, and highly transcribed genes, mirroring the epigenetic data from the ENCODE project. Notably, these cfDNA ac counts correlate strongly with RNA polymerase II activity and exhibit distinct expression patterns for known circadian genes. Additionally, cfDNA ac signals across gene bodies and promoters show strong correlations with whole blood gene expression levels defined by GTEx. This study illustrates the utility of cfDNA ac analysis for investigating epigenomics and gene expression, underscoring its potential for a wide range of clinical applications in precision medicine. Biological sciences/Biotechnology/Genomics/Personalized medicine Biological sciences/Biotechnology/Genomics/Epigenomics Biological sciences/Biotechnology/Genomics/Transcriptomics Full Text Additional Declarations Yes there is potential Competing Interest. D.A. and R.R. are co-founders and shareholders of Aqtual, Inc. All other authors are shareholders of Aqtual, Inc. Supplementary Files SupplementaryTableS1.xlsx SupplementaryTableS2.xlsx Cite Share Download PDF Status: Published Journal Publication published 04 Sep, 2024 Read the published version in Communications Biology → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-3983393","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":275422946,"identity":"b764f482-d432-45ed-9d2f-2cad16bf3532","order_by":0,"name":"Kevin Lai","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Kevin","middleName":"","lastName":"Lai","suffix":""},{"id":275422947,"identity":"88f40726-ef07-46eb-8b68-e4bade102479","order_by":1,"name":"Katharine Dilger","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Katharine","middleName":"","lastName":"Dilger","suffix":""},{"id":275422948,"identity":"8b3c2192-a58d-46b3-97d3-33c8e96c089b","order_by":2,"name":"Rachael Cunningham","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Rachael","middleName":"","lastName":"Cunningham","suffix":""},{"id":275422949,"identity":"9d7ed8c4-0431-4541-8978-7d490b072e11","order_by":3,"name":"Kathy Lam","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Kathy","middleName":"","lastName":"Lam","suffix":""},{"id":275422950,"identity":"2828a68f-27e3-450b-b932-246846083007","order_by":4,"name":"Rhea Boquiren","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Rhea","middleName":"","lastName":"Boquiren","suffix":""},{"id":275422951,"identity":"35ab1a19-c527-4f96-aea0-7ac3567e57f6","order_by":5,"name":"Khiet Troung","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Khiet","middleName":"","lastName":"Troung","suffix":""},{"id":275422952,"identity":"e0734a5a-ce56-4062-b082-aef87f3b5b24","order_by":6,"name":"Maggie Louie","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Maggie","middleName":"","lastName":"Louie","suffix":""},{"id":275422953,"identity":"264146ef-1b77-45e5-a3e0-c3408a9f0ae1","order_by":7,"name":"Richard Rava","email":"","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":false,"prefix":"","firstName":"Richard","middleName":"","lastName":"Rava","suffix":""},{"id":275422945,"identity":"cd8719a0-0037-4cf5-8193-5202c341e6d5","order_by":8,"name":"Diana Abdueva","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABAUlEQVRIiWNgGAWjYDCCwxAqgeEAiKoAcxgPkKDlDAMDD5DCr+UAshbGNiK08B1nfvbgB4NdHt+N5GMSP+fZye6XSH5wgKHGJhqXFsnDbOaGPQzJxZI30tIke7clG/dIpBkcYDiWltuAQ4vBYQYzCR4G5sQNN3KMDXi3MSf2SCQYHGBsOIxHC/s3yT8M9UAt+Z8N/86pB2pJ/0BAC4+ZNA/DYZAtjI95Gw4DteTgt0XyME+ZtIzB8WLJM88MH8scO27cc+ZNwYEEPH7hO398m+Sbiuo8vuPJDw6+qamWbW9P3/jgQ40NTi1Q5yGYjGCVCXiVowFG/IaPglEwCkbBSAQAhDVh4X5vKxYAAAAASUVORK5CYII=","orcid":"","institution":"Aqtual Inc.","correspondingAuthor":true,"prefix":"","firstName":"Diana","middleName":"","lastName":"Abdueva","suffix":""}],"badges":[],"createdAt":"2024-02-24 00:05:17","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-3983393/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-3983393/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s42003-024-06769-3","type":"published","date":"2024-09-04T04:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":64023703,"identity":"d4aa72ef-02b0-499c-8d5c-751f9ebfa05e","added_by":"auto","created_at":"2024-09-05 07:12:35","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2355437,"visible":true,"origin":"","legend":"","description":"","filename":"ExtractingRegulatoryChromatinFootprintfromCellFreeDNAv.2222024submitted.pdf","url":"https://assets-eu.researchsquare.com/files/rs-3983393/v1_covered_58eaefbb-f379-4d8f-89b7-fbc8e6de237e.pdf"},{"id":52395476,"identity":"05a972ec-f16f-4870-b099-1e97b84d2c95","added_by":"auto","created_at":"2024-03-11 05:06:33","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":21223,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryTableS1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-3983393/v1/21ee444bbc1108805426a2d2.xlsx"},{"id":52395475,"identity":"46dcd0e3-3258-4142-9b72-7bfb754cc639","added_by":"auto","created_at":"2024-03-11 05:06:33","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":23578,"visible":true,"origin":"","legend":"\u003cp\u003e\u003cbr\u003e\u003c/p\u003e","description":"","filename":"SupplementaryTableS2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-3983393/v1/fab51347c33b27a7e0329bd1.xlsx"}],"financialInterests":"\u003cb\u003eYes\u003c/b\u003e there is potential Competing Interest.\nD.A. and R.R. are co-founders and shareholders of Aqtual, Inc. All other authors are shareholders of Aqtual, Inc.","formattedTitle":"Extracting Regulatory Active Chromatin Footprint from Cell-Free DNA","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-3983393/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-3983393/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Cell-free DNA (cfDNA) has emerged as a pivotal player in precision medicine, revolutionizing the diagnostic and therapeutic landscape. While its clinical applications have significantly increased in recent years, current cfDNA assays have limited ability to identify the active transcriptional programs that govern complex disease phenotypes and capture the heterogeneity of the disease. To address these limitations, we have developed a non-invasive platform to enrich and examine the active chromatin fragments (cfDNA\u003csub\u003eac\u003c/sub\u003e) in peripheral blood. The deconvolution of the cfDNA\u003csub\u003eac\u003c/sub\u003e signal from traditional nucleosomal chromatin fragments (cfDNA\u003csub\u003enuc\u003c/sub\u003e) yields a catalog of features linking these circulating chromatin signals in blood to specific regulatory elements across the genome, including enhancers, promoters, and highly transcribed genes, mirroring the epigenetic data from the ENCODE project. Notably, these cfDNA\u003csub\u003eac\u003c/sub\u003e counts correlate strongly with RNA polymerase II activity and exhibit distinct expression patterns for known circadian genes. Additionally, cfDNA\u003csub\u003eac\u003c/sub\u003e signals across gene bodies and promoters show strong correlations with whole blood gene expression levels defined by GTEx. This study illustrates the utility of cfDNA\u003csub\u003eac\u003c/sub\u003e analysis for investigating epigenomics and gene expression, underscoring its potential for a wide range of clinical applications in precision medicine.","manuscriptTitle":"Extracting Regulatory Active Chromatin Footprint from Cell-Free DNA","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2024-03-11 05:06:28","doi":"10.21203/rs.3.rs-3983393/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"communications-biology","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"commsbio","sideBox":"Learn more about [Communications Biology](http://www.nature.com/commsbio/)","snPcode":"","submissionUrl":"","title":"Communications Biology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Communications Series","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"135e8acb-c1b5-4cd8-b7a1-664dcbfd79b9","owner":[],"postedDate":"March 11th, 2024","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":29033834,"name":"Biological sciences/Biotechnology/Genomics/Personalized medicine"},{"id":29033835,"name":"Biological sciences/Biotechnology/Genomics/Epigenomics"},{"id":29033836,"name":"Biological sciences/Biotechnology/Genomics/Transcriptomics"}],"tags":[],"updatedAt":"2024-09-05T07:12:26+00:00","versionOfRecord":{"articleIdentity":"rs-3983393","link":"https://doi.org/10.1038/s42003-024-06769-3","journal":{"identity":"communications-biology","isVorOnly":false,"title":"Communications Biology"},"publishedOn":"2024-09-04 04:00:00","publishedOnDateReadable":"September 4th, 2024"},"versionCreatedAt":"2024-03-11 05:06:28","video":"","vorDoi":"10.1038/s42003-024-06769-3","vorDoiUrl":"https://doi.org/10.1038/s42003-024-06769-3","workflowStages":[]},"version":"v1","identity":"rs-3983393","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-3983393","identity":"rs-3983393","version":["v1"]},"buildId":"qtupq5eGEP_6zYnWcrvyt","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00